*UKHotViewsExtra* Has DXC begun the "end-game" as Saleh sails away?

On 1st October, DXC Technology will formally part company with its US healthcare operations in the latest of a string of recent disposals by the ailing US technology company. The $5bn sale is part of a tranche of planned divestments announced in March this year that in total equates to around 30% of the company’s total revenue (see: DXC looks to reduce debt via US healthcare sale).

DXC Technology’s exit from the US healthcare market is notable not just for what the move represents but also because it will mark the departure of the company’s CFO, Paul Saleh, one of former CEO, Mike Lawrie’s most loyal lieutenants.

You can learn more about what the latest DXC divestment signifies by downloading Has DXC begun the "end-game" as Saleh sails away? which also contains our perspective on the simultaneous exit of the company’s longstanding CFO.

Has DXC begun the "end-game" as Saleh sails away? is available to all TechMarketView clients including HotViews Premium subscribers.

If you are not a TechMarketView subscriber, but would like access to or any of our other research material, you should contact Deb Seth.

Posted by: Jon C Davies at 06:30

Tags: DXC  

Add a comment